Cancers Engaged in Evolutionary Arms Race with Immune System
- Aggressive stomach and gullet cancers evolve escape routes under selective pressure from immune system - Findings underline importance of…
- Aggressive stomach and gullet cancers evolve escape routes under selective pressure from immune system - Findings underline importance of…
· Only 28 per cent of people believe cancers can be controlled long term – yet the average patient now…
Sarcoma UK is disappointed to see that life extending cancer drug trabectedin (Yondelis) will not be made available routinely on…
Researchers at Queen’s University Belfast have received the first scientific research grant from MDS UK to improve treatment for Myelodysplastic…
Immunotherapy pembrolizumab keeps some patients alive for three years or more Pembrolizumab either used alone or in combination with chemotherapy…
It is a while since I have written a blog. My disease has been stable for just over a year…
The inaugural London Global Cancer Week will launch at the Royal Society of Medicine on Monday 25 November. The week-long…
A new type of drug that blocks one of cancer’s key evolutionary escape routes from chemotherapy could be used to…
· First clinical study to show link between types of gut bacteria and radiotherapy-induced gut damage · Studying patients’ bacterial…
New Iridium compounds effective towards killing cancer cells even without the presence of oxygen – expanding the range of tumours…
NHS pilot found half of children had mutations in their tumours that would be targetable by drugs available for adults…
Cancer is most prevalent in senior age groups. According to the Centers for Disease Control and Prevention (CDC), there were…
This website uses cookies.